Search Results - "Lariviere, Jean P"

Refine Results
  1. 1
  2. 2

    Tissue pO2 of Orthotopic 9L and C6 Gliomas and Tumor-Specific Response to Radiotherapy and Hyperoxygenation by Khan, Nadeem, Ph.D, Li, Hongbin, Ph.D, Hou, Huagang, M.D, Lariviere, Jean P., B.S, Gladstone, David J., Sc.D, Demidenko, Eugene, Ph.D, Swartz, Harold M., M.D, Ph.D

    “…Purpose Tumor hypoxia is a well-known therapeutic problem; however, a lack of methods for repeated measurements of glioma partial pressure of oxygen (pO2 )…”
    Get full text
    Journal Article
  3. 3

    Repeated tumor pO2 measurements by multi-site EPR oximetry as a prognostic marker for enhanced therapeutic efficacy of fractionated radiotherapy by Hou, Huagang, Lariviere, Jean P, Demidenko, Eugene, Gladstone, David, Swartz, Harold, Khan, Nadeem

    Published in Radiotherapy and oncology (01-04-2009)
    “…Abstract Purpose To investigate the temporal effects of single or fractionated radiotherapy on subcutaneous RIF-1 tumor pO2 and to determine the therapeutic…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Effect of a Topical Vasodilator on Tumor Hypoxia and Tumor Oxygen Guided Radiotherapy using EPR Oximetry by Hou, Huagang, Abramovic, Zrinka, Lariviere, Jean P., Sentjurc, Marjeta, Swartz, Harold, Khan, Nadeem

    Published in Radiation research (01-05-2010)
    “…We sought to reduce tumor hypoxia by topical application of a vasodilator, benzyl nicotinate (BN), and investigated its effect on the growth of tumors…”
    Get full text
    Journal Article
  6. 6

    Synergistic combination of hyperoxygenation and radiotherapy by repeated assessments of tumor pO2 with EPR oximetry by Hou, Huagang, Dong, Ruhong, Lariviere, Jean P, Mupparaju, Sriram P, Swartz, Harold M, Khan, Nadeem

    Published in Journal of radiation research (2011)
    “…The effect of hyperoxygenation with carbogen (95% O(2) + 5% CO(2)) inhalation on RIF-1 tumor pO(2 )and its consequence on growth inhibition with fractionated…”
    Get full text
    Journal Article
  7. 7

    Repeated tumor pO(2) measurements by multi-site EPR oximetry as a prognostic marker for enhanced therapeutic efficacy of fractionated radiotherapy by Hou, Huagang, Lariviere, Jean P, Demidenko, Eugene, Gladstone, David, Swartz, Harold, Khan, Nadeem

    Published in Radiotherapy and oncology (01-04-2009)
    “…To investigate the temporal effects of single or fractionated radiotherapy on subcutaneous RIF-1 tumor pO(2) and to determine the therapeutic outcomes when the…”
    Get full text
    Journal Article
  8. 8

    Assessment of the Changes in 9L and C6 Glioma pO2 by EPR Oximetry as a Prognostic Indicator of Differential Response to Radiotherapy by Hou, Huagang, Mupparaju, Sriram P., Lariviere, Jean P., Hodge, Sassan, Gui, Jiang, Swartz, Harold M., Khan, Nadeem

    Published in Radiation research (01-03-2013)
    “…Tumor hypoxia impedes the outcome of radiotherapy. As the extent of hypoxia in solid tumors varies during the course of radiotherapy, methods that can provide…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Arsenic Alters the Function of the Glucocorticoid Receptor as a Transcription Factor by Kaltreider, Ronald C., Davis, Alisa M., Lariviere, Jean P., Hamilton, Joshua W.

    Published in Environmental health perspectives (01-03-2001)
    “…Chronic human exposure to nonovertly toxic doses of arsenic is associated with an increased risk of cancer. Although its carcinogenic mechanism is still…”
    Get full text
    Journal Article
  11. 11

    Synergistic Combination of Hyperoxygenation and Radiotherapy by Repeated Assessments of Tumor pO2 with EPR Oximetry by Huagang HOU, Ruhong DONG, Jean P.LARIVIERE, Sriram P.MUPPARAJU, Harold M.SWARTZ, Nadeem KHAN

    Published in JOURNAL OF RADIATION RESEARCH (2011)
    “…The effect of hyperoxygenation with carbogen (95% O2 + 5% CO2) inhalation on RIF-1 tumor pO2 and its consequence on growth inhibition with fractionated…”
    Get full text
    Journal Article
  12. 12

    Repeated tumor oximetry to identify therapeutic window during metronomic cyclophosphamide treatment of 9L gliomas by MUPPARAJU, Sriram, HUAGANG HOU, LARIVIERE, Jean P, SWARTZ, Harold, JOUNAIDI, Youssef, KHAN, Nadeem

    Published in Oncology reports (01-07-2011)
    “…Malignant gliomas are aggressive and angiogenic tumors with high VEGF content. Consequently, approaches such as metronomic chemotherapy, which have an…”
    Get full text
    Journal Article
  13. 13

    Tumor pO₂ as a surrogate marker to identify therapeutic window during metronomic chemotherapy of 9L gliomas by Mupparaju, Sriram, Hou, Huagang, Lariviere, Jean P, Swartz, Harold M, Khan, Nadeem

    “…Glioblastomas are aggressive and highly vascularized primary brain tumors with a 5-year survival rate of less than 10%. Approaches targeting tumor vasculature…”
    Get more information
    Journal Article
  14. 14

    Implantable resonators--a technique for repeated measurement of oxygen at multiple deep sites with in vivo EPR by Li, Hongbin, Hou, Huagang, Sucheta, Artur, Williams, Benjamin B, Lariviere, Jean P, Khan, Md Nadeem, Lesniewski, Piotr N, Gallez, Bernard, Swartz, Harold M

    “…EPR oximetry using implantable resonators allows measurements at much deeper sites than are possible with surface resonators (> 80 vs. 10 mm) and achieves…”
    Get more information
    Journal Article
  15. 15

    Synergistic Combination of Hyperoxygenation and Radiotherapy by Repeated Assessments of Tumor pO[sub.2] with EPR Oximetry by Hou, Huagang, Dong, Ruhong, Lariviere, Jean P, Mupparaju, Sriram P, Swartz, Harold M, Khan, Nadeem

    Published in Journal of radiation research (01-09-2011)
    “…The effect of hyperoxygenation with carbogen (95% O[sub.2] + 5% CO[sub.2]) inhalation on RIF-1 tumor pO[sub.2]and its consequence on growth inhibition with…”
    Get full text
    Journal Article
  16. 16

    Modulation of tumor hypoxia by topical formulations with vasodilators for enhancing therapy by Abramovic, Zrinka, Hou, Huagang, Julijana, Kristl, Sentjurc, Marjeta, Lariviere, Jean P, Swartz, Harold M, Khan, Nadeem

    “…Tumor hypoxia is a well known therapeutic problem which contributes to radioresistance and aggressive tumor characteristics. Lack of techniques for repeated…”
    Get more information
    Journal Article
  17. 17

    Radiotherapy in Conjunction with 7-Hydroxystaurosporine: A Multimodal Approach with Tumor pO2 as a Potential Marker of Therapeutic Response by Khan, Nadeem, Mupparaju, Sriram P., Hou, Huagang, Lariviere, Jean P., Demidenko, Eugene, Swartz, Harold M., Eastman, Alan

    Published in Radiation research (01-11-2009)
    “…Checkpoint inhibitors potentially could be used to enhance cell killing by DNA-targeted therapeutic modalities such as radiotherapy. UCN-01…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Assessment of the Changes in 9L and C6 Glioma pO2by EPR Oximetry as a Prognostic Indicator of Differential Response to Radiotherapy by Hou, Huagang, Mupparaju, Sriram P., Lariviere, Jean P., Hodge, Sassan, Gui, Jiang, Swartz, Harold M., Khan, Nadeem

    Published in Radiation research (01-03-2013)
    “…Tumor hypoxia impedes the outcome of radiotherapy. As the extent of hypoxia in solid tumors varies during the course of radiotherapy, methods that can provide…”
    Get full text
    Journal Article